Document is current
Any future updates will be listed below
-
Authors
Riihimäki, Matias
Hemminki, Akseli
Sundquist, Jan
Hemminki, Kari
- License Information
-
More Information
Article History
Received: 21 January 2016
Accepted: 16 June 2016
First Online: 15 July 2016
Competing interests
: AH is shareholder of Oncos Therapeutics, Ltd. A.H. is employee and shareholder in TILT Biotherapeutics, Ltd.
